{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:50:22Z","timestamp":1791575422200,"version":"4.3.4"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Long-term opioid use and associated adverse outcomes have increased dramatically in recent years. Limited research is available on long-term opioid use in older adults.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to determine the incidence and predictors of long-term or persistent opioid use (POU) amongst opioid-na\u00efve older adults without a cancer diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a retrospective cohort study using five national administrative healthcare databases in New Zealand. We included all opioid-na\u00efve older adults (\u226565\u00a0years) who were initiated on opioid therapy between January 2013 and June 2018. The outcome of interest was POU, defined as having continuously filled \u22651 opioid prescription within 91\u2013180\u00a0days after the index opioid prescription. Multivariable logistic regression was used to examine the predictors of POU.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The final sample included 268,857 opioid-na\u00efve older adults; of these, 5,849(2.2%) developed POU. Several predictors of POU were identified. The use of fentanyl (adjusted odds ratio (AOR)\u2009=\u20093.61; 95% confidence interval (CI) 2.63\u20134.95), slow-release opioids (AOR\u2009=\u20093.02; 95%CI 2.78\u20133.29), strong opioids (AOR\u2009=\u20092.03; 95%CI 1.55\u20132.65), Charlson Comorbidity Score\u2009\u2265\u20093 (AOR\u2009=\u20092.09; 95% CI 1.78\u20132.46), history of substance abuse (AOR\u2009=\u20091.52; 95%CI 1.35\u20131.72), living in most socioeconomically deprived areas (AOR\u2009=\u20091.40; 95%CI 1.27\u20131.54), and anti-epileptics (AOR\u2009=\u20092.07; 95%CI 1.89\u20132.26), non-opioid analgesics (AOR\u2009=\u20092.05; 95%CI 1.89\u20132.21), antipsychotics (AOR\u2009=\u20091.96; 95%CI 1.78\u20132.17) or antidepressants (AOR\u2009=\u20091.50; 95%CI 1.41\u20131.59) medication use were the strongest predictors of POU.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>A significant proportion of patients developed POU, and several factors were associated with POU. The findings will enable healthcare providers and policymakers to target early interventions to prevent POU and related adverse events.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ageing\/afad167","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T17:18:15Z","timestamp":1693675095000},"source":"Crossref","is-referenced-by-count":6,"title":["Predictors of persistent opioid use in non-cancer older adults: a retrospective cohort study"],"prefix":"10.1093","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1057-2593","authenticated-orcid":false,"given":"Kebede","family":"Beyene","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical and Administrative Sciences, University of Health Sciences and Pharmacy , St. Louis, MO, USA"},{"name":"School of Pharmacy , Faculty of Medical and Health Sciences, , Auckland, New Zealand"},{"name":"The University of Auckland , Faculty of Medical and Health Sciences, , Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Fahmy","sequence":"additional","affiliation":[{"name":"School of Pharmacy , Faculty of Medical and Health Sciences, , Auckland, New Zealand"},{"name":"The University of Auckland , Faculty of Medical and Health Sciences, , Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Hai Yan","family":"Chan","sequence":"additional","affiliation":[{"name":"School of Pharmacy , Faculty of Medical and Health Sciences, , Auckland, New Zealand"},{"name":"The University of Auckland , Faculty of Medical and Health Sciences, , Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tomlin","sequence":"additional","affiliation":[{"name":"School of Pharmacy , Faculty of Medical and Health Sciences, , Auckland, New Zealand"},{"name":"The University of Auckland , Faculty of Medical and Health Sciences, , Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine , School of Medicine, , Auckland, New Zealand"},{"name":"The University of Auckland , School of Medicine, , Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"2023090217180969100_ref1","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/pds.1833","article-title":"Trends in long-term opioid therapy for chronic non-cancer pain","volume":"18","author":"Boudreau","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2023090217180969100_ref2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jpain.2005.11.006","article-title":"Opioid prescriptions by U.S. primary care physicians from 1992 to 2001","volume":"7","author":"Olsen","year":"2006","journal-title":"J Pain"},{"key":"2023090217180969100_ref3","doi-asserted-by":"crossref","first-page":"e2145691","DOI":"10.1001\/jamanetworkopen.2021.45691","article-title":"Factors associated with opioid overdose after an initial opioid prescription","volume":"5","author":"Weiner","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2023090217180969100_ref4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11606-009-1218-z","article-title":"Relationship of opioid use and dosage levels to fractures in older chronic pain patients","volume":"25","author":"Saunders","year":"2010","journal-title":"J Gen Intern Med"},{"key":"2023090217180969100_ref5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/JPR.S244173","article-title":"The modified WHO analgesic ladder: is it appropriate for chronic non-cancer pain?","volume":"13","author":"Yang","year":"2020","journal-title":"J Pain Res"},{"key":"2023090217180969100_ref6","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1503\/cmaj.170363","article-title":"Guideline for opioid therapy and chronic noncancer pain","volume":"189","author":"Busse","year":"2017","journal-title":"CMAJ"},{"key":"2023090217180969100_ref7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ageing\/afz175","article-title":"A systematic review of the evidence for the efficacy of opioids for chronic non-cancer pain in community-dwelling older adults","volume":"49","author":"O\u2019Brien","year":"2020","journal-title":"Age Ageing"},{"key":"2023090217180969100_ref8","article-title":"A review of potential adverse effects of long-term opioid therapy: a practitioner's guide","volume":"14","author":"Baldini","year":"2012","journal-title":"Prim Care Companion CNS Disord"},{"key":"2023090217180969100_ref9","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/ageing\/afab048","article-title":"The effect of opioids on the cognitive function of older adults: results from the personality and total health through life study","volume":"50","author":"Neelamegam","year":"2021","journal-title":"Age Ageing"},{"key":"2023090217180969100_ref10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.mayocp.2020.02.002","article-title":"Opioids in older adults: indications, prescribing, complications, and alternative therapies for primary care","volume":"95","author":"Gazelka","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"2023090217180969100_ref11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2042098615615472","article-title":"Predicting risk of adverse drug reactions in older adults","volume":"7","author":"Lavan","year":"2016","journal-title":"Ther Adv Drug Saf"},{"key":"2023090217180969100_ref12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/bcp.12762","article-title":"Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study","volume":"81","author":"Vozoris","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"2023090217180969100_ref13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1183\/13993003.01967-2015","article-title":"Incident opioid drug use and adverse respiratory outcomes among older adults with COPD","volume":"48","author":"Vozoris","year":"2016","journal-title":"Eur Respir J"},{"key":"2023090217180969100_ref14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/SLA.0000000000002461","article-title":"Incidence and risk factors of long-term opioid use in elderly trauma patients","volume":"268","author":"Daoust","year":"2018","journal-title":"Ann Surg"},{"key":"2023090217180969100_ref15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/M19-3600","article-title":"Predictors of prolonged opioid use after initial prescription for acute musculoskeletal injuries in adults a systematic review and meta-analysis of observational studies","volume":"173","author":"Riva","year":"2020","journal-title":"Ann Intern Med"},{"key":"2023090217180969100_ref16"},{"key":"2023090217180969100_ref17","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"2023090217180969100_ref18","doi-asserted-by":"crossref","first-page":"l6691","DOI":"10.1136\/bmj.l6691","article-title":"Rethinking \"long term\" opioid therapy","volume":"367","author":"Abdel Shaheed","year":"2019","journal-title":"BMJ"},{"key":"2023090217180969100_ref19","volume-title":"National Collections [Internet]"},{"key":"2023090217180969100_ref20","volume-title":"StatPearls","author":"Anekar","year":"2023"},{"key":"2023090217180969100_ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain \u2013 United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"2023090217180969100_ref22","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jamainternmed.2016.3298","article-title":"Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period","volume":"176","author":"Sun","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2023090217180969100_ref23","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1007\/s00268-019-05016-9","article-title":"Chronic postoperative opioid use: a systematic review","volume":"43","author":"Hinther","year":"2019","journal-title":"World J Surg"},{"key":"2023090217180969100_ref24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neubiorev.2017.01.039","article-title":"Age changes in pain perception: a systematic-review and meta-analysis of age effects on pain and tolerance thresholds","volume":"75","author":"Lautenbacher","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"2023090217180969100_ref25","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/pme.12773","article-title":"Pharmaceutical opioid use and dependence among people living with chronic pain: associations observed within the pain and opioids in treatment (POINT) cohort","volume":"16","author":"Campbell","year":"2015","journal-title":"Pain Med"},{"key":"2023090217180969100_ref26","first-page":"e146","article-title":"Prescription opioid registry protocol in an integrated health system","volume":"23","author":"Ray","year":"2017","journal-title":"Am J Manag Care"},{"key":"2023090217180969100_ref27","doi-asserted-by":"crossref","first-page":"e1003270","DOI":"10.1371\/journal.pmed.1003270","article-title":"Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: a retrospective cohort study","volume":"17","author":"Jani","year":"2020","journal-title":"PLoS Med"},{"key":"2023090217180969100_ref28","first-page":"11","article-title":"Inequity in outcomes from New Zealand chronic pain services","volume":"134","author":"Lewis","year":"2021","journal-title":"N Z Med J"},{"key":"2023090217180969100_ref29","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/pme.12528","article-title":"Associations of socioeconomic position and pain prevalence in the United States: findings from the national health and nutrition examination survey","volume":"15","author":"Riskowski","year":"2014","journal-title":"Pain Med"},{"key":"2023090217180969100_ref30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/j.pain.0000000000000762","article-title":"Sociodemographic disparities in chronic pain, based on 12-year longitudinal data","volume":"158","author":"Grol-Prokopczyk","year":"2017","journal-title":"Pain"},{"key":"2023090217180969100_ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-019-2477-4","article-title":"Factors associated with chronic and acute back pain in wales, a cross-sectional study","volume":"20","author":"Jonsdottir","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"2023090217180969100_ref32","doi-asserted-by":"crossref","first-page":"750193","DOI":"10.3389\/fphar.2021.750193","article-title":"Geographical, socioeconomic, and gender inequalities in opioid use in Catalonia","volume":"12","author":"Serra-Pujadas","year":"2021","journal-title":"Front Pharmacol"},{"key":"2023090217180969100_ref33","first-page":"21","article-title":"Ethnic disparities in attendance at New Zealand\u2019s chronic pain services","volume":"131","author":"Lewis","year":"2018","journal-title":"N Z Med J"},{"key":"2023090217180969100_ref34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5694\/mja15.00174","article-title":"Safety of opioid patch initiation in Australian residential aged care","volume":"203","author":"Gadzhanova","year":"2015","journal-title":"Med J Aust"},{"key":"2023090217180969100_ref35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jemermed.2011.03.011","article-title":"Recurrent respiratory depression associated with fentanyl transdermal patch gel reservoir ingestion","volume":"42","author":"D\u2019Orazio","year":"2012","journal-title":"J Emerg Med"},{"key":"2023090217180969100_ref36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States, 2006-2015","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023090217180969100_ref37","doi-asserted-by":"crossref","first-page":"e0210341","DOI":"10.1371\/journal.pone.0210341","article-title":"Patterns and predictors of chronic opioid use in older adults: a retrospective cohort study","volume":"14","author":"Oh","year":"2019","journal-title":"PloS One"},{"key":"2023090217180969100_ref38","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/bcp.13556","article-title":"Predictors of persistent prescription opioid analgesic use among people without cancer in Australia","volume":"84","author":"Lalic","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"2023090217180969100_ref39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.drugalcdep.2012.09.018","article-title":"Abuse liability and reinforcing efficacy of oral tramadol in humans","volume":"129","author":"Babalonis","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"2023090217180969100_ref40","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ageing\/afs199","article-title":"Guidance on the management of pain in older people","volume":"42","author":"Abdulla","year":"2013","journal-title":"Age Ageing"},{"key":"2023090217180969100_ref41","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"key":"2023090217180969100_ref42","first-page":"85","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med"},{"key":"2023090217180969100_ref43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ageing\/afs178","article-title":"Opioids, antiepileptic and anticholinergic drugs and the risk of fractures in patients 65 years of age and older: a prospective population-based study","volume":"42","author":"Nurminen","year":"2013","journal-title":"Age Ageing"},{"key":"2023090217180969100_ref44","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s11096-012-9681-8","article-title":"Inappropriate prescribing in hospitalised australian elderly as determined by the STOPP criteria","volume":"34","author":"Wahab","year":"2012","journal-title":"Int J Clin Pharmacol"},{"key":"2023090217180969100_ref45","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2147\/CIA.S161052","article-title":"Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP. PAIN. DEM)","volume":"13","author":"Erdal","year":"2018","journal-title":"Clin Interv Aging"},{"key":"2023090217180969100_ref46","doi-asserted-by":"crossref","first-page":"i4784","DOI":"10.1136\/bmj.i4784","article-title":"US drug labels to warn of risks of combining opioids and benzodiazepines","volume":"354","author":"McCarthy","year":"2016","journal-title":"BMJ"},{"key":"2023090217180969100_ref47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/schbul\/sbab116","article-title":"Risk of overdose associated with co-prescription of antipsychotics and opioids: a population-based cohort study","volume":"48","author":"Szmulewicz","year":"2022","journal-title":"Schizophr Bull"},{"key":"2023090217180969100_ref48","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/bcp.14715","article-title":"Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: a five-year prospective cohort study","volume":"87","author":"Nielsen","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"2023090217180969100_ref49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.9740\/mhc.2021.07.225","article-title":"Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids","volume":"11","author":"Desai","year":"2021","journal-title":"Ment Health Clin"},{"key":"2023090217180969100_ref50","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/0306-3623(94)90365-4","article-title":"The effect of lithium on morphine-induced analgesia in mice","volume":"25","author":"Dehpour","year":"1994","journal-title":"Gen Pharmacol"},{"key":"2023090217180969100_ref51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbr.2003.08.022","article-title":"Inhibition of morphine analgesia by lithium: role of peripheral and central opioid receptors","volume":"151","author":"Johnston","year":"2004","journal-title":"Behav Brain Res"},{"key":"2023090217180969100_ref52","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s11606-018-4335-8","article-title":"Prediction of future chronic opioid use among hospitalized patients","volume":"33","author":"Calcaterra","year":"2018","journal-title":"J Gen Intern Med"},{"key":"2023090217180969100_ref53","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s10067-020-05085-5","article-title":"Long-term opioid use among patients with chronic gout: a cross-sectional study of a sample cohort in South Korea","volume":"39","author":"Oh","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2023090217180969100_ref54","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/acr.23928","article-title":"Prescription opioid use among patients with acute gout discharged from the emergency department","volume":"72","author":"Dalal","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2023090217180969100_ref55","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s10067-019-04526-0","article-title":"Gout and chronic pain in older adults: a Medicare claims study","volume":"38","author":"Singh","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2023090217180969100_ref56","doi-asserted-by":"crossref","first-page":"e000483","DOI":"10.1136\/bmjresp-2019-000483","article-title":"Respiratory events associated with concomitant opioid and sedative use among medicare beneficiaries with chronic obstructive pulmonary disease","volume":"7","author":"Le","journal-title":"BMJ Open Respir Res"},{"key":"2023090217180969100_ref57","article-title":"Oral or transdermal opioids for osteoarthritis of the knee or hip","author":"Costa","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2023090217180969100_ref58","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinternmed.2010.273","article-title":"Emergency department visits among recipients of chronic opioid therapy","volume":"170","author":"Braden","year":"2010","journal-title":"Arch Intern Med"},{"key":"2023090217180969100_ref59","article-title":"Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain","author":"NICE","year":"2021","journal-title":"Methods"},{"key":"2023090217180969100_ref60","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"key":"2023090217180969100_ref61","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pain.2007.01.014","article-title":"Development and validation of the current opioid misuse measure","volume":"130","author":"Butler","year":"2007","journal-title":"Pain"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/52\/9\/afad167\/51332349\/afad167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/52\/9\/afad167\/51332349\/afad167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T17:18:38Z","timestamp":1693675118000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afad167\/7258774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afad167","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,1]]},"published":{"date-parts":[[2023,9,1]]},"article-number":"afad167"}}